The Myths and Facts of Intrauterine Contraception Bleeding Profiles

This supplement is supported by Teva Women's Health, Inc.
April 1, 2011|ObGyn
Author and Disclosure Information

 

Marya B. Margolis, PharmD, MPH
Dr. Margolis is Senior Director, Medical Affairs, Teva Women’s Health Research, Inc, Horsham, Penn.

Miriam Zieman, MD, FACOG
Dr. Zieman is Clinical Associate Professor, Emory University, Atlanta, Ga.

Jay Cohen, MD, FACOG
Dr. Cohen is Medical Director, Sheridan Clinical Research, Inc, and Discovery Clinical Research, Inc, Fort Lauderdale, Fla.

Henry Hess, MD, PhD
Dr. Hess is Clinical Professor, Obstetrics and Gynecology, University of Rochester School of Medicine, Rochester, NY.

Diana Ramos, MD, MPH, FACOG
Dr. Ramos is Assistant Clinical Professor, Obstetrics and Gynecology, University of Southern California Keck School of Medicine, Los Angeles, Calif.

Suzy Reiter, WHNP-BC, MM, MSN, SANE-A, FAANP
Dr. Reiter is Clinician, Largo Health Center, Largo, Fla; and Immediate Past President of the National Certification Corporation of Obstetric, Gynecologic and Neonatal Nursing Specialties.

Changes in bleeding patterns as a result of contraceptive use are a frequent cause of method discontinuation and unintended pregnancy. Because many contraceptive methods alter uterine bleeding, particularly during the critical early weeks and months of use, it is important that clinicians counsel patients on this topic.

,false